The Statement of Objections is also addressed to Merck KGaA, Generics UK, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma, A.L. Industrier and Ranbaxy, which belonged to the generic groups that concluded the agreements.
La communication des griefs est aussi adressée à Merck KgaA, Generics UK, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma, A.L. Industrier et Ranbaxy, qui faisaient partie du groupe des fabricants de produits génériques ayant conclu des accords.